Quick Answer
CYTOKINETICS INC reported Cash And Cash Equivalents At Carrying Value of $122.52 million for the year ending 2025.
- CYTOKINETICS INC showed an increase of +29.2% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from CYTOKINETICS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $18.37 million | Q3 2010: $30.44 million | Q1 2011: $15.45 million | Q2 2011: $23.77 million | Q3 2011: $18.59 million | Q1 2012: $17.82 million | Q2 2012: $63.65 million | Q3 2012: $15.39 million | Q1 2013: $13.16 million | Q2 2013: $17.06 million | Q3 2013: $19.26 million | Q1 2014: $13.26 million | Q2 2014: $12.36 million | Q3 2014: $12.91 million | Q1 2015: $22.55 million | Q2 2015: $24.84 million | Q3 2015: $25.96 million | Q1 2016: $42.27 million | Q2 2016: $27.72 million | Q3 2016: $30.30 million | Q4 2016: $66.87 million | Q1 2017: $49.36 million | Q2 2017: $100.71 million | Q3 2017: $116.32 million | Q1 2018: $115.01 million | Q2 2018: $46.96 million | Q3 2018: $27.62 million | Q1 2019: $39.41 million | Q2 2019: $34.36 million | Q3 2019: $39.63 million | Q1 2020: $49.78 million | Q2 2020: $61.13 million | Q3 2020: $200.81 million | Q1 2021: $44.59 million | Q2 2021: $37.15 million | Q3 2021: $90.56 million | Q1 2022: $115.42 million | Q2 2022: $93.63 million | Q3 2022: $106.24 million | Q1 2023: $101.62 million | Q2 2023: $68.64 million | Q3 2023: $99.69 million | Q1 2024: $119.98 million | Q2 2024: $190.14 million | Q3 2024: $46.89 million | Q1 2025: $73.68 million | Q2 2025: $74.94 million | Q3 2025: $225.47 million.
- Over the full 18 years of available data (2008 to 2025), CYTOKINETICS INC's Cash And Cash Equivalents At Carrying Value has grown by 193.0%.
- Historical annual values: Fiscal year 2025: $122.52 million | Fiscal year 2024: $94.86 million | Fiscal year 2023: $113.02 million | Fiscal year 2022: $65.58 million | Fiscal year 2021: $112.67 million | Fiscal year 2020: $82.99 million | Fiscal year 2019: $36.43 million | Fiscal year 2018: $42.26 million | Fiscal year 2017: $125.21 million | Fiscal year 2016: $66.87 million | Fiscal year 2015: $65.08 million | Fiscal year 2014: $20.22 million | Fiscal year 2013: $20.16 million | Fiscal year 2012: $14.91 million | Fiscal year 2011: $18.83 million | Fiscal year 2010: $17.51 million | Fiscal year 2009: $25.56 million | Fiscal year 2008: $41.82 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: